At a glance
What is it—and why does it matter?
GHK‑Cu denotes the copper(II) chelate/complex of the tripeptide glycyl‑L‑histidyl‑L‑lysine (a copper tripeptide).
Sources for this introduction: [1]
This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.
What is it?
A molecule, not a product name.
Identity
Copper tripeptide-1 is listed as one component of the proprietary Scarcede™ blend in ThriveCo Scar Fader Gel.
- Source records
- 1
- Independent studies
- 1
Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.
Exact passages, locators, and provenance
- supports · Source-backed record
“ThriveCo Scar Fader Gel containing Scarcede™ (Anveya Living Private Limited, Bengaluru, India), a proprietary blend of copper tripeptide-1, L-carnitine L-tartrate, alpha-glucosyl hesperidin, and sodium hyaluronate.”
Efficacy and Safety Assessment of ThriveCo Scar Fader Gel With Scarcede™ in the Treatment of Skin Scars. · Abstract
pubmed:41001334:d3e230705ca3:d3e230705ca3
Identity
GHK‑Cu denotes the copper(II) chelate/complex of the tripeptide glycyl‑L‑histidyl‑L‑lysine (a copper tripeptide).
- Source records
- 1
- Independent studies
- 1
Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.
Exact passages, locators, and provenance
- supports · Source-backed record
“GHK-Cu (Glycyl-L-histidyl-L-lysine copper(II)) complex”
ATorilis japonicaExtract-GHK-Cu Complex Attenuates Th2 Cytokines and Promotes Keratinocyte Recovery: A Potential Antioxidant Strategy for Atopic Dermatitis. · Abstract
pubmed:42510549:8ec0ee54d50f:8ec0ee54d50f
How does it work?
Target, response, and disposition.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
What has been studied?
What the evidence says.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Risks and interactions
Risks, organized for scanning.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Products and regulatory status
Same ingredient. Different records.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Administration context
The practical clinical context.
This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.
Research status + gaps
What still needs better answers?
- No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
- 44 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (34), assurance_score_below_0.72 (10), current_regulatory_source_required (5), extraction_ambiguity (42), high_risk_requires_regulatory_or_two_independent_sources (10), no_direct_support (44), proposal_not_staged (2)
These are the limits of this profile, not an exhaustive list of scientific uncertainties.
References + discovery
Open the records yourself.
- Efficacy and Safety Assessment of ThriveCo Scar Fader Gel With Scarcede™ in the Treatment of Skin Scars. ↗
pubmed · published 2025-08-01 · retrieved 2026-08-26T08:42:26Z
- ATorilis japonicaExtract-GHK-Cu Complex Attenuates Th2 Cytokines and Promotes Keratinocyte Recovery: A Potential Antioxidant Strategy for Atopic Dermatitis. ↗
pubmed · published 2026-06-29 · retrieved 2026-08-26T08:42:26Z
Publication history and provenance
Version 4 · Automated assessment · 2026-09-04T19:14:59Z
28d4f106d8174ea87e39e9a9d19147a1f87f858bb77123aceb65717c1e2ea6b0